Program Supplement [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Oral Sessions
[ PL02 1
09:15 TuOrl44 Kasia Malinowska-Sempruch will be
introduced by Joan Colom i Ferrer (Spain)
08:55 TuOrl43 HIV Vaccines - Update on the Science
and Policy, Lawrence Corey (United
States) is the title of this presentation
B06 1
11:45 TuOrB149 Translating Science in to Practice:
Moving from PMTCT to MCT Plus, Chewe
Luo (UNICEF) is the title of this
presentation
14:20 TuOr159 Clinical impact, Pablo Tebas (United
States) has the new time Slot of 14:15
14:40 TuOr16o It's disturbing, Jon Willis (United States)
has the new time slot of 14:30
15:oo TuOr161 Impact on body image and sexuality,
Catherine Williams (Trinidad and Tobago)
has the new time slot of 14:45
16:oo TuOrB175 Update from the HIV Drug Resistance
Workshop, Douglas R Richman (United
States) is the new title of this
presentation
16:45 TuOrB176 Clinical pharmacology of HIV Therapy in
2002, David Back (United Kingdom) is
the title of this presentation
16:45 TuOrB177 Update on 3rd international workshop on
clinical pharmacologyof HIV therapy,
David Burger (The Netherlands) is the
title of this presentation
SYFO1
16:oo TuOrF178 Integrating peer prevention into care in
Peru will be presented by Pablo
Anamaria Cardenas (Peru)
Poster Presentations
[PPE021
21:30 TuPpE2o67 Achieving competency-based
assessment and training of Australian
HIV/AIDS peer educators, JA Wylie,
M McMahon, A Madden (Australia)
replaces the abstract which appears
in the Final Program
Changes of Presenting Author
Oral Sessions
16:oo TuOr17o Drug development for TB prophylaxis,
speaker to be announced
[EO5

[G06I

16:45 TuOrG1247

Poster Exhibitions
TuPeB4496
TuPeB4645
TuPeC4686
TuPeC487o
TuPeC4884
TuPeF5462
TuPeG5689

An exploration of the individual cost
effectiveness and the population level
efficacy of a rationed anti-retroviral
treatment program in South Africa will be
presented by A Boulle
Frequency and clinical significance of
pancreatic abnormalities during HIV
disease: to treat or not to treat? will be
presented by F Chiodo
Effectiveness of dual and triple treatment
regimens in HIV-infected children in Belo
Horizonte, Brazil will be presented by
A J Pinto
The threat of HIV/AIDS in the Middle
East and North Africa region will be
presented by D Robalino
The impact of STARHS 'deturned assay'
results on HIV incidence calculations in
an ongoing cohort of men who have sex
with men (MSM) in Vancouver will be
presented by E Press
Use of rapid HIV test kits in Indonesia
will be presented by J Kumalawati
High risk behaviors in msm in six U.S.
cities: call for new, more intensive
prevention efforts will be presented by
P Barresi
Towards improved common ethical
standards and procedures for research in
developing countries will be presented
by J A Gastaut

Withdrawn Abstracts
Poster Presentations
[PEO21

12:30 TuPpE2o67
Poster Exhibitions
TuPeB4431
TuPeB4566
TuPeD4927
TuPeE5121
TuPeFS459

The research/practice interface -
supporting evidence based HIV practice
Phase i multiple oral dose safety and
pharmacokinetic study of S-1360, an HIV
integrase inhibitor with healthy volunteers
Correlation of nelfinavir efficacy,
pharmacokinetics (PK) and use of
antacids in treatment-naive H IV positive
patients receiving nelfinavir and 2
nucleosides
The projects of prevention of HIV in
Argentina: the perspective of AIDSA's
NGOs
The cost of treating HIV/AIDS in South
Africa
Sex workers intervention in healthy
highways project: some issues for future
action

14:30 TuOrE12o4

Perceived faith-based invulnerability to
HIV infection among female sex workers
in Nigeria will be presented by
Z Akinyemi

XIV International AIDS Conference BARCELONA - JULY 7-12

57